Manav Vildan, Erdil Duygu, Koku Aksu Ayşe Esra
Department of Dermatology, University of Health Sciences, İstanbul Training and Research Hospital, İstanbul, Turkey.
Cosmetology, İstanbul University Graduate School of Medicine, İstanbul, Turkey.
Dermatol Pract Concept. 2023 Apr 1;13(2). doi: 10.5826/dpc.1302a81.
Hair loss is one of the most common disorders after coronavirus disease 2019 (COVID-19) infection. This study aimed to investigate the relationship between COVID-19-related hair loss and antinuclear antibody (ANA) positivity and patterns.
ANA positivity and patterns were analyzed in 30 female COVID-19 patients with hair loss complaints and compared in terms of the presence of autoimmunity between patients with and without COVID-19 exhibiting hair loss.
ANA positivity and cytoplasmic patterns were detected in 40% of the patients with COVID-19 infection and hair loss. Trichodynia and diffuse hair loss were observed in 63.3% and 53.3%, respectively.
In patients with COVID-19-related hair loss, diffuse hair loss and ANA positivity may be related to the high antibody levels triggered by COVID-19 infection.
脱发是2019冠状病毒病(COVID-19)感染后最常见的病症之一。本研究旨在调查COVID-19相关脱发与抗核抗体(ANA)阳性及模式之间的关系。
对30例有脱发主诉的COVID-19女性患者的ANA阳性及模式进行分析,并比较有和没有COVID-19相关脱发患者的自身免疫情况。
40%的COVID-19感染且脱发患者检测到ANA阳性及胞质模式。分别有63.3%和53.3%的患者出现拔毛痛和弥漫性脱发。
在COVID-19相关脱发患者中,弥漫性脱发和ANA阳性可能与COVID-19感染引发的高抗体水平有关。